Immunovant

$42.19
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.58 (+1.39%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Immunovant and other stocks, options, and ETFs commission-free!

About IMVT

Immunovant, Inc. Common Stock, also called Immunovant, is a clinical-stage biopharmaceutical company. It focuses on enabling normal lives for patients with autoimmune diseases. The company was founded in 2018 and is headquartered in New York, NY. The listed name for IMVT is Immunovant, Inc. Common Stock.

CEO

Peter Salzmann

Employees

—

Headquarters

New York, New York

Founded

2018

Market Cap

4.22B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

437.05K

High Today

$43.55

Low Today

$41.25

Open Price

$41.25

Volume

333.38K

52 Week High

$53.75

52 Week Low

$8.34

Collections

Analyst Ratings

100%

of 11 ratings

Buy

100%

Hold

Sell

IMVT Earnings

-$0.38

-$0.25

-$0.13

$0.00

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Mar 29, Pre-Market